Free Cash Flow Chart

Historical Free Cash Flow Data

View and export this data back to 2016. Start Trial.
Date Value
March 31, 2026 -10.27M
September 30, 2025 -10.67M
March 31, 2025 -15.63M
September 30, 2024 -13.94M
March 31, 2024 -9.374M
September 30, 2023 -11.16M
March 31, 2023 -10.57M
September 30, 2022 -7.986M
March 31, 2022 -11.98M
September 30, 2021 -12.30M
Date Value
March 31, 2021 -7.176M
September 30, 2020 -4.728M
March 31, 2020 -3.923M
September 30, 2019 -3.485M
March 31, 2019 -3.222M
September 30, 2018 -3.538M
March 31, 2018 -2.619M
September 30, 2017 -2.324M
March 31, 2017 -2.072M
September 30, 2016 -2.170M

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
Proteome Sciences Plc --
Ixico Plc -4.225M
ICON plc 893.97M
Champions Oncology, Inc. -6.137M
Silence Therapeutics Plc -41.79M

Free Cash Flow Related Metrics